These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 1979813)

  • 1. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discrimination studies with MDMA and amphetamine.
    Oberlender R; Nichols DE
    Psychopharmacology (Berl); 1988; 95(1):71-6. PubMed ID: 2898791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA).
    Baker LE; Broadbent J; Michael EK; Matthews PK; Metosh CA; Saunders RB; West WB; Appel JB
    Behav Pharmacol; 1995 Apr; 6(3):263-275. PubMed ID: 11224335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination.
    Baker LE; Taylor MM
    Pharmacol Biochem Behav; 1997 Aug; 57(4):737-48. PubMed ID: 9259001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties and possible risks.
    Aerts LA; Mallaret M; Rigter H
    Addict Biol; 2000 Jul; 5(3):269-82. PubMed ID: 20575841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
    Marona-Lewicka D; Nichols DE
    Eur J Pharmacol; 1994 Jun; 258(1-2):1-13. PubMed ID: 7925587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes.
    Nakagawa Y; Suzuki T; Tayama S; Ishii H; Ogata A
    Arch Toxicol; 2009 Jan; 83(1):69-80. PubMed ID: 18553070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity.
    Paulus MP; Geyer MA
    Neuropsychopharmacology; 1992 Aug; 7(1):15-31. PubMed ID: 1355968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of the optical isomers of 3,4-methylenedioxyamphetamine (MDA).
    Broadbent J; Appel JB; Michael EK; Ricker JH
    Behav Pharmacol; 1992 Oct; 3(5):443-454. PubMed ID: 11224147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
    Gatch MB; Rutledge MA; Carbonaro T; Forster MJ
    Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2016 Sep; 27(6):497-505. PubMed ID: 27028902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.
    Johanson CE; Kilbey M; Gatchalian K; Tancer M
    Drug Alcohol Depend; 2006 Jan; 81(1):27-36. PubMed ID: 15975736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA).
    Johnson MP; Frescas SP; Oberlender R; Nichols DE
    J Med Chem; 1991 May; 34(5):1662-8. PubMed ID: 1674539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats.
    Mori T; Uzawa N; Kazawa H; Watanabe H; Mochizuki A; Shibasaki M; Yoshizawa K; Higashiyama K; Suzuki T
    J Pharmacol Exp Ther; 2014 Aug; 350(2):403-11. PubMed ID: 24917544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA).
    Nichols DE; Brewster WK; Johnson MP; Oberlender R; Riggs RM
    J Med Chem; 1990 Feb; 33(2):703-10. PubMed ID: 1967651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.
    Callaway CW; Geyer MA
    Eur J Pharmacol; 1992 Apr; 214(1):45-51. PubMed ID: 1349861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA.
    Rangisetty JB; Bondarev ML; Chang-Fong J; Young R; Glennon RA
    Pharmacol Biochem Behav; 2001; 69(1-2):261-7. PubMed ID: 11420094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM.
    Glennon RA
    Pharmacol Biochem Behav; 1993 Oct; 46(2):459-62. PubMed ID: 7903460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.